Weekly treatment with oral alendronate maintains bone mineral increases gained after one year of romosozumab treatment, in women with chronic spinal cord injury
Overall, one year of treatment with monthly romosozumab followed by one year of treatment with weekly alendronate, significantly increased and maintained bone mineral at the hip, but not the knee, in women with chronic SCI and secondary osteoporosis.
Authors
- Thomas J. Schnitzer
- Laura E. Crack (ORCID: https://orcid.org/0000-0003-4863-7177)
- Narina Simonian (ORCID: https://orcid.org/0000-0003-1943-3730)
- Reza Kakavand
- W. Brent Edwards
Institutions
- University of Calgary (CA)
Publication Details
- Journal
- Journal of Spinal Cord Medicine
- Published
- 2026-01-14
- DOI
- https://doi.org/10.1080/10790268.2025.2607828
- Primary Topic
- Spinal Cord Injury Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00